Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fernandez T."" wg kryterium: Wszystkie pola


Tytuł :
Valores de referencia de hormonas tiroideas en la población de gestantes en Lugo
Autorzy :
Álvarez Fernández, T.
González Vilanova, M.M.
Bal Alvaredo, M.J.
Sánchez Pérez-Mel, M.C.
Máiz Suárez, L.
Pokaż więcej
Alternatywny tytuł :
Reference values of thyroid hormones in the population of pregnant in Lugo (English)
Źródło :
In Clinica e Investigacion en Ginecologia y Obstetricia October-December 2020 47(4):143-148
Czasopismo naukowe
Tytuł :
Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications
Autorzy :
Lamim Lovatel V
de Souza Fernandez C
Ferreira Rodrigues E
de Cassia Tavares R
Sobral da Costa E
Abdelhay E
Coelho Soares Lima S
de Souza Fernandez T
Pokaż więcej
Temat :
pediatric myelodysplastic syndrome
dnmts
tet2
apobec3b.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :
Cancer Management and Research, Vol Volume 12, Pp 543-556 (2020)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/expression-profiles-of-dna-methylation-and-demethylation-machinery-com-peer-reviewed-article-CMAR; https://doaj.org/toc/1179-1322
Dostęp URL :
https://doaj.org/article/7fdd1c56f818464ca83f75861ecdbecb
Czasopismo naukowe
Tytuł :
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Autorzy :
Čelutkienė J; Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; State Research Institute Centre For Innovative Medicine, Vilnius, Lithuania.
Pudil R; First Department of Medicine - Cardioangiology, Charles University Prague, Medical Faculty and University Hospital Hradec Králové, Hradec Kralove, Czech Republic.
López-Fernández T; Cardiology Department, La Paz University Hospital, IdiPAz, Ciber CV, Madrid, Spain.
Grapsa J; Department of Cardiology, St Bartholomew Hospital, Barts Health Trust, London, UK.
Nihoyannopoulos P; Unit of Inherited Cardiovascular Diseases/Heart Center of the Young and Athletes, First Department of Cardiology, Hippokrateion General Hospital, National and Kapodistrian University of Athens, Athens, Greece.; National Heart and Lung Institute Imperial College London, Hammersmith Hospital, London, UK.
Bergler-Klein J; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Cohen-Solal A; UMR-S 942, Cardiology Department, Hôpital Lariboisière, AP-HP, Université de Paris, Paris, France.
Farmakis D; University of Cyprus Medical School, Nicosia, Cyprus.; Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
Tocchetti CG; Department of Translational Medical Sciences, and Interdepartmental Center for Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy.
von Haehling S; Department of Cardiology and Pneumology, University of Göttingen Medical Centre, Göttingen, Germany.
Barberis V; American Medical Center, American Heart Institute, Nicosia, Cyprus.
Flachskampf FA; Department of Medical Sciences, Uppsala University, Clinical Physiology and Cardiology, Akademiska Hospital, Uppsala, Sweden.
Čeponienė I; Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Haegler-Laube E; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Suter T; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Lapinskas T; Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Prasad S; Department of Cardiac Magnetic Resonance, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK.
de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Wechalekar K; Department of Nuclear Medicine, Royal Brompton Hospital, London, UK.
Anker MS; Division of Cardiology and Metabolism, Department of Cardiology, Charité; and Berlin Institute of Health Center for Regenerative Therapies (BCRT); and DZHK (German Centre for Cardiovascular Research), partner site Berlin; and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany.
Iakobishvili Z; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Tel Aviv-Jaffa District, Clalit Health Services, Tel Aviv, Israel.
Bucciarelli-Ducci C; Bristol Heart Institute, Bristol NIHR Biomedical Research Centre and Clinical Research and Imaging Centre (CRIC) Bristol, University Hospitals Bristol NHS Trust and University of Bristol, Bristol, UK.
Schulz-Menger J; Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center a joint cooperation between the Charité - Universitätsmedizin Berlin, Department of Internal Medicine and Cardiology and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Cosyns B; Department of Cardiology, CHVZ (Centrum voor Hart en Vaatziekten), ICMI (In Vivo Cellular and Molecular Imaging) Laboratory, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Gaemperli O; Heart Clinic Hirslanden, Hirslanden Hospital, Zurich, Switzerland.
Belenkov Y; I.M. Sechenov's First Moscow State Medical University of Ministry of Health (Sechenov University), Moscow, Russia.
Hulot JS; Université de Paris, CIC1418, Paris Cardiovascular Research Center, INSERM, Paris, France.
Galderisi M; Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy.
Lancellotti P; University of Liège Hospital, GIGA Cardiovascular Sciences, Department of Cardiology, CHU SartTilman, Liège, Belgium.
Bax J; Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
Marwick TH; Baker Heart and Diabetes Institute, Melbourne, Australia.
Chioncel O; Emergency Institute for Cardiovascular Diseases C.C. Iliescu, Bucuresti, Romania.; University of Medicine Carol Davila, Bucuresti, Romania.
Jaarsma T; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
Mullens W; Ziekenhuis Oost Limburg, University Hasselt, Genk, Belgium.
Piepoli M; Heart Failure Unit, Cardiology, Guglielmo da Saliceto Hospital, Piacenza, Italy.; University of Parma, Parma, Italy.
Thum T; Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany.
Heymans S; Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; William Harvey Research Institute, Barts Heart Centre, Queen Mary University of London, Charterhouse Square, London, UK.; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
Mueller C; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
Moura B; Cardiology Department, Military Hospital, and CINTESIS, CardioCare, Faculty of Medicine, Porto University, Porto, Portugal.
Ruschitzka F; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Zamorano JL; Cardiology Department, University Hospital Ramón y Cajal, Madrid, Spain.; University Alcala, Madrid, Spain.; CIBERCV, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Rosano G; Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.; Cardiology Clinical Academic Group, St George's Hospitals NHS Trust University of London, London, UK.
Coats AJS; IRCCS San Raffaele Pisana, Rome, Italy.
Asteggiano R; Cardiologist in Practice, Turin, Italy.
Seferovic P; University of Belgrade Faculty of Medicine and Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Edvardsen T; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Lyon AR; National Heart and Lung Institute, Imperial College, London, UK.; Cardio-Oncology Service, Royal Brompton Hospital, London, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2020 Sep; Vol. 22 (9), pp. 1504-1524. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The cancer patient and cardiology.
Autorzy :
Zamorano JL; Department of Cardiology, University Hospital Ramón y Cajal, CiberCV, Madrid, Spain.
Gottfridsson C; Cardiovascular Safety Centre of Excellence, Patient Safety, CMO Organization, AstraZeneca, Gothenburg, Sweden.
Asteggiano R; ESC Council of Cardio-Oncology, Insubria University of Medicine, Varese, Italy.; LARC (Laboratorio Analisi Ricerca Clinica), Turin, Italy.
Atar D; Department of Cardiology, Oslo University Hospital Ulleval, Oslo, Norway.; Institute of Clinical Sciences, University of Oslo, Oslo, Norway.
Badimon L; ESC Advocacy Committee 2018-2020, Director Cardiovascular Programme (ICCC)-IR Hospital de la Santa Creu I Sant Pau, CiberCV, Barcelona, Spain.
Bax JJ; Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands.
Cardinale D; Cardio-Oncology Unit, European Institute of Oncology, IRCCS, Milan, Italy.
Cardone A; European Cancer Patient Coalition, Brussels, Belgium.
Feijen EAM; Princess Maxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; Pharmahungary Group, Szeged, Hungary.
López-Fernández T; Department of Cardiology, University Hospital La Paz, IdiPAZ, Ciber CV, Madrid, Spain.
Gale CP; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Maduro JH; Department of Radiation Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Moslehi J; Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, TN, USA.
Omland T; Department of Cardiology, Akershus University Hospital, University of Oslo, Oslo, Norway.
Plana Gomez JC; Department of Cardiology, Texas Heart Institute and Baylor College of Medicine, Houston, TX, USA.
Scott J; Exercise Oncology Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Suter TM; Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland.
Minotti G; Campus Bio-Medico University School of Medicine, Rome, Italy.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2020 Aug 18. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Autorzy :
Lyon AR; Cardio-Oncology Service, Royal Brompton Hospital and Imperial College, London, UK.
Dent S; Duke Cancer Institute, Duke University, Durham, NC, USA.
Stanway S; Breast Unit, Royal Marsden Hospital, Surrey, UK.
Earl H; Department of Oncology, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Brezden-Masley C; Division of Medical Oncology, Sinai Health System, Mount Sinai Hospital, Toronto, Canada.
Cohen-Solal A; UMR-S 942, Paris University, Cardiology Department, Lariboisiere Hospital, AP-HP, Paris, France.
Tocchetti CG; Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy.
Moslehi JJ; Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Groarke JD; Cardio-Oncology Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Bergler-Klein J; Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Khoo V; Department of Clinical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Department of Medical Imaging and Radiation Sciences, Monash University and Department of Medicine, Melbourne University, Melbourne, Australia.
Tan LL; Department of Cardiology, National University Heart Centre, Singapore, National University Health System, Singapore, Singapore.
Anker MS; Division of Cardiology and Metabolism, Department of Cardiology, Charité and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research), partner site Berlin and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany.
von Haehling S; Department of Cardiology and Pneumology, University of Goettingen Medical Center, Goettingen, Germany.; German Center for Cardiovascular Research (DZHK), partner site Goettingen, Goettingen, Germany.
Maack C; Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany.
Pudil R; First Department of Medicine - Cardioangiology, Charles University Prague, Medical Faculty and University Hospital Hradec Kralove, Prague, Czech Republic.
Barac A; MedStar Heart and Vascular Institute, Georgetown University, Washington, DC, USA.
Thavendiranathan P; Ted Rogers Program in Cardiotoxicity Prevention and Joint Division of Medical Imaging, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
Ky B; University of Pennsylvania, Philadelphia, PA, USA.
Neilan TG; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Belenkov Y; Sechenov Medical University, Moscow, Russia.
Rosen SD; Cardio-Oncology Service, Royal Brompton Hospital and Imperial College, London, UK.
Iakobishvili Z; Department of Community Cardiology, Tel Aviv Jaffa District, Clalit Health Fund and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sverdlov AL; School of Medicine and Public Health, University of Newcastle and 'Cancer and the Heart' Program, Hunter New England LHD, Newcastle, Australia.
Hajjar LA; Cardio-Oncology, Department of Cardio-Pneumology, University of São Paulo, São Paulo, Brazil.
Macedo AVS; Santa Cardio-Oncology, Santa Casa de São Paulo and Rede Dor São Luiz, São Paulo, Brazil.
Manisty C; Barts Heart Centre and University College London, London, UK.
Ciardiello F; Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy.
Farmakis D; University of Cyprus Medical School, Nicosia, Cyprus.; Cardio-Oncology Clinic, Heart Failure Unit, 'Attikon' University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
de Boer RA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Skouri H; Cardiology Division, Internal Medicine Department, American University of Beirut Medical Center, Beirut, Lebanon.
Suter TM; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Cardinale D; Cardioncology Unit, European Institute of Oncology, IRCCS, Milan, Italy.
Witteles RM; Stanford University School of Medicine, Stanford, CA, USA.
Fradley MG; University of Pennsylvania, Philadelphia, PA, USA.
Herrmann J; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Cornell RF; Vanderbilt University Medical Center, Nashville, TN, USA.
Wechelaker A; National Amyloidosis Centre, University College London, London, UK.
Mauro MJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Milojkovic D; Department of Haematology, Hammersmith Hospital, Imperial College, London, UK.
de Lavallade H; Department of Haematological Medicine, King's College Hospital, London, UK.
Ruschitzka F; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Coats AJS; University of Warwick, Warwick, UK.; Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy.
Seferovic PM; Faculty of Medicine and Serbian Academy of Sciences and Arts, University of Belgrade, Belgrade, Serbia.
Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.; University of Medicine Carol Davila, Bucharest, Romania.
Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Andres MS; Cardio-Oncology Service, Royal Brompton Hospital and Imperial College, London, UK.
Wright DJ; Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
López-Fernández T; Cardiology Service, Cardio-Oncology Unit, La Paz University Hospital and IdiPAz Research Institute, Ciber CV, Madrid, Spain.
Plummer C; Department of Cardiology, The Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle, UK.
Lenihan D; Cardio-Oncology Center of Excellence, Washington University in St Louis, St Louis, MO, USA.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2020 May 28. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC)
Autorzy :
Barnadas, A.
Algara, M.
Cordoba, O.
Casas, A.
Gonzalez, M.
Marzo, M.
Montero, A.
Muñoz, M.
Ruiz, A.
Santolaya, F.
Fernandez, T.
Pokaż więcej
Źródło :
Clinical and Translational Oncology. 20(6):687-694
Czasopismo naukowe
Tytuł :
Bilateral serous retinal detachments associated with IgA nephropathy
Autorzy :
Andión-Fernández, M.
Dorado-Fernández, T.
Juárez-Casado, M.A.
Santamarina-Pernas, R.
Pokaż więcej
Alternatywny tytuł :
Desprendimientos de retina serosos bilaterales asociados a glomerulonefritis primaria por depósito de Inmunoglobulina A (Spanish; Castilian)
Źródło :
In Archivos de la Sociedad Española de Oftalmología (English Ed) November 2015 90(11):531-535
Czasopismo naukowe
Tytuł :
Patterns in sexual reproduction of the dominant scleractinian corals at Rapa Nui (Easter Island): Pocillopora verrucosa and Porites lobata
Autorzy :
Buck-Wiese, H
Burguès, I
Medrano, A
Navarrete-Fernandez, T
Garcia, M
Wieters, EA
Pokaż więcej
Temat :
Biology (General)
QH301-705.5
Microbiology
QR1-502
Źródło :
Aquatic Biology , Vol 27, Pp 1-11 (2018)
Opis pliku :
electronic resource
Relacje :
https://www.int-res.com/abstracts/ab/v27/p1-11/; https://doaj.org/toc/1864-7782; https://doaj.org/toc/1864-7790
Dostęp URL :
https://doaj.org/article/c5bdf8a087dc415490f83eadb30b3eca
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies